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ABSTRACT 
Objective: To develop a novel, accurate, precise and linear reverse phase high performance liquid chromatographic (RP-HPLC) method for 
simultaneous quantitative estimation of gabapentin and amitriptyline hydrochloride in gabantip-at tablet and validate as per international 
conference on harmonization (ICH) guidelines and to perform the force degradation studies using the developed method. 
Methods: In the present work, good chromatographic separation was achieved isocratically using a shim-pack HPLC C18 column (4.6 x 250 mm, 5μm) 
and mobile phase consisting of 0.05 M potassium dihydrogen orthophosphate pH 2.1 adjusted with orthophosphoric acid and acetonitrile in the ratio 
(55:45), at flow rate 1 ml/min and column temperature (25 °C). The effluents obtained were monitored at 221 nm with the UV-visible detector. 
Results: The retention time of gabapentin and amitriptyline hydrochloride was found to be 1.959 min and 4.221 min respectively. The linearity of 
gabapentin was found in the range of 720-1680 ppm and that for amitriptyline hydrochloride was found to be 24-56 ppm. The correlation 
coefficient for gabapentin and amitriptyline hydrochloride were 0.999 and 0.9963 respectively. The high recovery values (98%-101%) indicate a 
satisfactory accuracy. The low percent relative standard deviation (% RSD) values in the precision study reveals that the method is precise. 
Conclusion: The developed method is novel, simple, precise, rapid, accurate and reproducible for simultaneous estimation of gabapentin and 
amitriptyline hydrochloride tablet dosage form. Hence the proposed method may find practical applications as a quality-control tool in the 
simultaneous analysis of the two drugs in combined dosage forms in quality-control laboratories. 
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The IUPAC name of the gabapentin and amitriptyline hydrochloride 
is 2-[1-(aminomethyl) cyclohexyl] acetic acid and 3-(5,6-
dihydrodibenzo[2,1-b: 2',1'-f] 7-annulen-11-ylidene)-N,N-dimethyl-
propan-1-amine respectively, with molecular formula C9H17NO2 and 
C20H23N. HCl respectively and molecular weight 207.70 and 313.87 
respectively [1, 2]. Gabapentin is freely soluble in water, alkaline and 
acidic solution, sparingly soluble in methanol [1]. Amitriptyline 
hydrochloride is freely soluble in water and in alcohol [2]. The 
molecular structure of the drugs is given in fig. 1. 
 
 
Fig. 1: Chemical structure of (a) gabapentin and (b) 
amitriptyline hydrochloride [1, 2] 
 
Gabapentin is an antiepileptic medication. It decreases pain and 
seizures by modulating calcium channel activity of the nerve cells [1] 
and amitriptyline is used in the treatment of depression and 
neuropathic pain. Amitriptyline increases the levels of chemical 
messengers in the brain that help in regulating the mood and treat 
depression [2, 3]. 
Combination therapy of gabapentin and amitriptyline hydrochloride is 
used for the treatment of neuropathic pain, depression and seizures. 
Combination of gabapentin and nortriptyline is also available in the 
market but the fact is amitriptyline is more effective in the treatment 
of endogenous depressive illness then nortriptyline [4] and it should 
remain in its position as the gold-standard antidepressant [5].  
Literature survey reveals that various analytical and HPLC methods 
for estimation of gabapentin and amitriptyline hydrochloride were 
reported alone and in combination with other drugs in bulk, dosage 
forms, human plasma and in urine sample [1, 2, 6-16]. Also, HPLC 
methods have been reported for gabapentin and nortriptyline 
hydrochloride combination [17, 18] but to the best of our knowledge, 
there is no such reported HPLC analysis method for simultaneous 
estimation of gabapentin and amitriptyline hydrochloride 
combination. Hence, the aim of the present study was to develop a 
rapid and precise RP-HPLC method for the simultaneous estimation of 
gabapentin and amitriptyline hydrochloride in the combined dosage 
form and validate the developed method in accordance with ICH 
guidelines and also to perform the force degradation studies using the 
developed method. This novel validated method has applicability in 
the industry as well as academia. 
MATERIALS AND METHODS 
Gabapentin (99% potency) and amitriptyline hydrochloride (99% 
potency) were purchased from Chem dyes Corporation, Rajkot-
Gujarat. A commercial preparation gabantip-at tablet ‘Sun 
Pharmaceutical Industries Ltd’ containing gabapentin 300 mg and 
amitriptyline hydrochloride 10 mg used for analysis was procured 
from local market. HPLC grade solvents were purchased from 
Thomas Baker. RP-HPLC shimadzu (LC 2030) model with “Lab 
Solution” software was employed in this method. Analytical 
column used for the separation of analytes was shim-pack HPLC 
C18 (250 X 4.6 mm, 5 µm). 
Methods 
Selection of wavelength 
The suitable wavelength for the HPLC analysis was determined by 
recording UV spectrums in the range of 190-380 nm for individual 
drug solutions of amitriptyline hydrochloride and gabapentin then 
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overlapped. UV overlain spectra of both gabapentin and 
amitriptyline hydrochloride showed that both the drugs absorb 
appreciably at 221 nm and hence 221 nm was taken as a detection 
wavelength for HPLC analysis (fig. 2). 
 
 
Fig. 2: UV overlap spectrum of amitriptyline hydrochloride and gabapentin 
 
Chromatographic conditions 
The method was developed using reverse phase, shim-pack HPLC 
C18 column (250 X 4.6 mm, 5 µm). The runtime was of 7 min. The 
mobile phase used was 0.05 M potassium dihydrogen 
orthophosphate pH 2.1 adjusted with orthophosphoric acid and 
acetonitrile in the ratio (55:45) at a flow rate of 1.0 ml/min, column 
temperature (25 °C) and a detection wavelength of 221 nm using a 
UV-visible detector. 
Preparation of 0.05 M phosphate buffer (pH 2.1) 
About 6.80 g of potassium dihydrogen orthophosphate was 
accurately weighed and dissolved in 950 ml of water. The pHwas 
adjusted to 2.1 with orthophosphoric acid and the volume was made 
up to 1000 ml in a volumetric flask. The solution was then filtered 
using 0.45 µ membrane filter. 
Preparation of standard solution 
100 mg of amitriptyline hydrochloride and 300 mg of gabapentin 
standard were accurately weighed and transferred into 100 ml 
volumetric flask respectively. About 70 ml solvent was added, 
sonicated to dissolve and diluted up to the mark using a solvent 
(1000 ppm of amitriptyline hydrochloride and 3000 ppm of 
gabapentin). The final concentration of amitriptyline hydrochloride 
and gabapentin were made to 40 ppm and 1200 ppm respectively by 
suitable dilutions. 
Preparation of sample solution 
10 tablets were weighed and powdered. The quantity of powder 
equivalent to 10 mg of amitriptyline hydrochloride and 300 mg 
of gabapentin was transferred into a 100-ml volumetric flask. 
About 70 ml solvent was added and the solution was sonicated 
for 30 min with intermittent shaking. The volume was made up 
using the solvent, mixed and filtered through 0.45 µ PVDF filter. 
Final concentrations of amitriptyline hydrochloride and 
gabapentin were made to 40 ppm and 1200 ppm respectively 
with suitable dilution. 
Forced degradation studies  
Forced degradation is the process of subjecting drug compounds to 
extreme chemical and environmental conditions to determine 
product breakdown levels and preliminary degradation kinetics, and 
to identify potential degradation products. They are used to facilitate 
the development of analytical methodology, to gain a better 
understanding of active pharmaceutical ingredient and drug product 
stability, and to provide information about degradation pathways 
and degradation products. The study involves acid and alkali 
hydrolysis wherein sample solution was treated with 0.1 N HCl and 
0.1 N NaOH respectively at room temperature for 2 h. Oxidative 
degradation studies involved 30% v/v H2O2 treatment of sample 
solution at room temperature for 2 h. The samples were placed in 
hot air oven at 105 °C for 1 h to study thermal degradation. For 
photolytic stress studies, samples were exposed in photostability 
chamber for 5 h. The sample was placed in a humidity chamber at 25 
°C and 80 % RH (relative humidity) for 24 h to study degradation by 
humidity [19, 20]. 
RESULTS AND DISCUSSION  
Method development  
A reverse phase HPLC method was developed keeping in mind the 
system suitability parameters i.e. resolution factor between peaks, 
tailing factor, a number of theoretical plates, runtime and the cost-
effectiveness. The developed optimized method resulted in the 
elution of gabapentin at 1.9 min and amitriptyline hydrochloride at 
4.2 min. Fig. 3, 4 and 5 represent chromatograms of the blank 
solution, gabapentin standard solution and amitriptyline 
hydrochloride standard solution respectively.  
The total run time was 7 min. System suitability tests are an integral 
part of method development and are used to ensure adequate 
performance of the chromatographic system. Retention time, a 
number of theoretical plates, peak resolution and peak tailing factor 
were evaluated for six replicate injections of the standard working 
concentration. The results given in table 1 were within acceptable 
limits [21]. 
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Fig. 3: Typical chromatogram of blank solution 
 
 
Fig. 4: Typical chromatogram of gabapentin standard solution 
 
 
Fig. 5: Typical chromatogram of amitriptyline hydrochloride standard solution 
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Table 1: Results of system suitability studies 
Parameters Acceptance limits Amitriptyline hydrochloride Gabapentin 
Retention time - 4.221 min 1.959 min 
Resolution factor Not less than 2 13.575  
Number of Theoretical plate Not less than 2000 9450 2415 
Tailing factor Not more than 2 1.355 1.508 
 
In order to test the applicability of the developed method to a 
commercial formulation, ‘gabantip-at’ tablets were 
chromatographed at working concentration and it is shown in fig. 6. 
The sample peaks were identified by comparing the relative 
retention times with standard drugs (fig 4-5). System suitability 
parameters were within the acceptance limits, ideal for the 
chromatographed sample. Integration of separated peak area was 
done and each drug concentration was determined by using the peak 
area concentration relationship obtained in the standardization step. 
The protocol affords reproducible quantification of the two drugs 
with an error less than 10 %, which is the standard level in any 
pharmaceutical quality control. 
 
 
Fig. 6: Typical chromatogram of the sample 
 
Method validation 
Validation of the analytical method is the process that establishes by 
laboratory studies in which the performance characteristics of the 
method meet the requirements for the intended analytical 
application. HPLC method developed was validated according to ICH 
guidelines [22] for validation of analytical procedures. The method 
was validated for the parameters like linearity, accuracy, system 
precision, method precision, robustness, limit of detection and limit 
of quantitation. 
Specificity 
Fig. 3-6 for a blank solution, standard drug solutions and sample 
chromatogram reveal that the peaks obtained in the standard 
solutions and sample solution at working concentrations are only 
because of the drugs as blank has no peak at the retention time of 
gabapentin and amitriptyline hydrochloride. Accordingly, it can be 
concluded that the method developed is said to be specific [23]. 
Precision 
System precision 
Six replicate injections of the standard solutions at working 
concentration showed percent relative standard deviation (% RSD) 
less than 2 concerning peak area for both the drugs, which indicates 
the acceptable reproducibility and thereby the precision of the 
system [24, 25]. System precision results are tabulated in table 2. 
Method precision  
Method precision was determined by performing the assay of the sample 
under the test of repeatability (intraday precision) at working 
concentration. Six injections of the sample from the same homogeneous 
mixture at working concentration showed % RSD less than 2 concerning 
% assay for both the drugs which indicate that the method developed is 
method precise by the test of repeatability [24, 25] and hence can be 
understood that the method gives consistently reproducible results 
(table 3). 
 
Table 2: System precision results 
S. No. Peak area of amitriptyline hydrochloride (40 ppm) Peak area of gabapentin (1200 ppm) 
1 2325911 382152 
2 2331400 382984 
3 2341426 386194 
4 2338850 385431 
5 2343853 387636 
6 2341335 386683 
Average 2337129 385180 
SD 6971 2162 
%RSD 0.30 0.56 
#SD: Standard deviation, #% RSD: Percent relative standard deviation 
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Table 3: Method precision results 
S. No. Amitriptyline hydrochloride % assay  Gabapentin % assay 
1 99.31 99.70 
2 99.98 99.20 
3 100.92 100.20 
4 99.48 100.20 
5 100.35 99.70 
6 99.58 100.30 
Average 100.10 99.90 
SD 8.40 4.30 
%RSD 0.84 0.43 
#SD: Standard deviation, #%RSD: Percent relative standard deviation 
 
Linearity 
Standard solutions of amitriptyline hydrochloride and gabapentin 
at different concentrations level (60%, 80%, 100%, 120%, and 
140%) were prepared in triplicates. Calibration curves were 
constructed by plotting the concentration level versus 
corresponding peak areas for both the drugs. The results show an 
excellent correlation between peak areas and concentrations level 
within the tested concentration range of 24-56 ppm for 
amitriptyline hydrochloride and 720-1680 ppm for gabapentin 
(table 4). The correlation coefficients were greater than 0.99 for 
both the drugs, which meet the method validation acceptance 
criteria [24, 25] and hence the method is said to be linear for both 
the drugs (fig. 7-9). 
 
Table 4: Data for linearity studies 
% level  Amitriptyline hydrochloride  Gabapentin  
Concentration in ppm Peak area Concentration in ppm Peak area 
60 24 1420116 720 242796 
80 32 1951615 960 311701 
100 40 2325911 1200 382152 
120 48 2834560 1440 445676 
140 56 3389963 1680 514464 
Slope  60283  282.36 
Y intercept -26887  40557 
Correlation Coefficient  0.9963  0.999 
 
 
Fig. 7: Chromatogram of gabapentin and amitriptyline hydrochloride (five different concentration overlapped for linearity study) 
 
 
Fig. 8: Calibration curve of amitriptyline hydrochloride 
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Fig. 9: Calibration curve of gabapentin 
 
Accuracy 
Accuracy was determined by means of recovery experiments, by the 
determination of % mean recovery of both the drugs in the 
formulation at three different levels (80-120%). At each level, three 
determinations were performed. Percent mean recovery was 
calculated as shown in table 5 and 6. The accepted limits of mean 
recovery are 98%-102% and all observed data were within the 
required range, which indicates good recovery values, affirming the 
accuracy of the method developed [24, 25]. 
  
Table 5: Accuracy data for gabapentin 














80 600 480 1080 350140 1096.41 101.51 
100 600 600 1200 382152 1209.78 100.81 
120 600 720 1320 412115 1315.90  99.68 
 #n: Number of injections 
 
Table 6: Accuracy data for amitriptyline hydrochloride 
















80 20 16 36 2166897 36.39 101.08 
100 20 20 40 2338911 39.24  98.11 
120 20 24 44 2632705 44.11 100.26 
#n: Number of injections 
 
Robustness 
To determine the robustness of the developed method, 
experimental conditions were deliberately altered, and the system 
suitability parameter retention time and peak area were 
evaluated. The solution was prepared as per the test method 
described earlier and injected at different variable conditions like 
flow rate (0.8 ml/min and 1.2 ml/min.), column temperature (23 °C 
and 27 °C) and detection wavelength (220 nm and 222 nm). 
Robustness data clearly shows that the proposed method is robust 
at small but deliberate change [24, 25]. Robustness data are given 
in table 7. 
 
Table 7: Robustness data for amitriptyline hydrochloride and gabapentin 










Minus flow [0.8 ml/min] 4.378 2333114 98.98 2.095 390069 100.98 
Plus flow [1.2 ml/min] 4.037 2331637 98.85 1.833 379152 98 
Minus temperature [23 °C] 4.201 2334597 99.04 1.902 384137 99.03 
Plus temperature [27 °C] 4.218 2334147 99.02 1.961 383627 98.49 
Minus wavelength [220 nm] 4.221 2401311 101.1 1.961 392955 101.15 
Plus wavelength [222 nm] 4.223 2331910 98.92 1.961 381593 98.22 
 #n: Number of injections 
 
Sensitivity  
The sensitivity of measurement of amitriptyline hydrochloride and 
gabapentin by use of the proposed method was estimated in terms 
of the limit of quantitation (LOQ) and limit of detection (LOD). LOQ 
and LOD were calculated by the use of the equations LOD = 3.3σ/S 
and LOQ = 10σ/S where σ is the standard deviation of intercepts of 
calibration plots and S is the average of the slopes of the 
corresponding calibration plot. 
The LOD for amitriptyline hydrochloride and gabapentin were found 
to be 0.26 ppm and 41.90 ppm respectively, while LOQ for 
Shaikh et al. 
Int J App Pharm, Vol 10, Issue 2, 2018, 97-104 
103 
amitriptyline hydrochloride and gabapentin were found to be 0.81 
ppm and 126.97 ppm respectively. 
Solution stability 
Sample solution was injected at different time interval and % 
assay was calculated.  
The sample solution was found to be stable at room temperature if 
protected from light and moisture.  
The solution stability of 72 h indicated that the sample solution 
can be used over a period of 72 h without any degradation of the 
solution (table 8). 
 
Table 8: Solution stability data of amitriptyline hydrochloride and gabapentin 
Time % assay (amitriptyline hydrochloride) % assay (gabapentin) 
Initial 99.16 99.15 
After 1 d 99.14 99.11 
After 2 d 99.17 99.17 
After 3 d 99.15 99.16 
 
Forced degradation studies  
Forced degradation studies were performed to demonstrate the stability 
of the sample in different stressed conditions. The conditions used were 
acid and base hydrolysis, dry heat, oxidation, humidity and photolysis. 
The % assay of the amitriptyline hydrochloride and gabapentin with 
respect to untreated samples and % assay results obtained after treating 
the samples with various stress conditions had a difference which was 
within the acceptable limits. There was slightly higher degradation in UV, 
heat and humidity treated sample with respect to amitriptyline 
hydrochloride which indicates that it is unstable in these conditions and 
thus amitriptyline hydrochloride should be protected from light, 
moisture and direct heat, whereas it is relatively stable in acidic and 
basic condition. Gabapentin undergoes some amount of degradation in 
UV treated sample and base treated sample, slightly higher degradation 
when treated with hydrogen peroxide. Gabapentin is stable in acidic 
condition. As there was no interference observed from any components 
of the pharmaceutical dosage form or degrading products, hence it 
concludes that the developed method is stability indicating a method for 
simultaneous estimation of amitriptyline hydrochloride and gabapentin 
in the pharmaceutical dosage form. The data for forced degradation are 
tabulated in table 9. 
 
Table 9: Data for force degradation study 
Condition Amitriptyline hydrochloride Gabapentin 
% assay % Difference w. r. t. control % assay % Difference w. r. t. control 
Untreated sample 99.31 NA 99.70 NA 
Acid treated sample 98.31 01 99.20 0.5 
Base treated sample 98.11 1.2 96.70 03 
Peroxide treated sample 98.31 01 91.70 08 
Heat treated sample 95.31 04 98.20 1.5 
UV treated sample 88.29 11 97.70 02 
Humidity treated sample 92.31 07 98.70 01 
 
The results obtained from above set of observations prove that the 
method is useful in the qualitative and quantitative analysis of the 
drugs from the synthetic mixture and tablet formulation. Moreover, 
various analytical and HPLC methods for estimation of gabapentin and 
amitriptyline hydrochloride were reported alone and in combination 
with other drugs [1,2, 6-18] but as yet there is no reported HPLC 
analysis method for simultaneous estimation of gabapentin and 
amitriptyline hydrochloride combination and the novel method 
developed in this report is the first of its kind. This study reveals that 
the estimations can be done within 72 h at least, without having any 
detrimental effect on drug stability. The developed method is based on 
the use of a very economical solvent, had short chromatographic time 
and hence can be performed with ease. 
CONCLUSION 
A validated RP-HPLC method was developed for simultaneous 
estimation of gabapentin and amitriptyline hydrochloride in the 
pharmaceutical dosage form. This novel HPLC method found to be 
simple, precise, accurate and had a short chromatographic time. The 
solution stability of 72 h indicated that the sample solution can be used 
over a period of 72 h without any degradation of the solution. The 
developed method was validated as per the ICH guidelines and the 
results obtained were well within the limits. Percent recovery and 
estimated concentration of active ingredient in pharmaceutical 
formulations showed that the amount of drug present is consistent 
with the label claim. Hence the proposed method was found to be 
satisfactory and can be applied for the analysis of gabapentin and 
amitriptyline hydrochloride in pharmaceutical dosage forms. This 
method can be utilized in routine quantitative and qualitative analysis 
of gabapentin and amitriptyline hydrochloride in pharmaceutical 
formulation and to study degradation pathway. These results indicate 
that the proposed method may find practical applications as a quality-
control tool in the simultaneous analysis of the two drugs in combined 
dosage forms in quality-control laboratories. 
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